Clinical Trial: A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma.

Brief Summary: To demonstrate that the intraocular pressure(IOP)-lowering efficacy of Travoprost (0.004%) is equal or better than that of Latanoprost 0.005% in patients with chronic angle-closure glaucoma.

Detailed Summary:
Sponsor: Alcon Research

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Alcon Research

Dates:
Date Received: January 3, 2003
Date Started: January 2000
Date Completion:
Last Updated: August 4, 2008
Last Verified: August 2008